Braveheart Bio seeks $319M in IPO backed by a16z, signaling VC firm’s expanding appetite beyond crypto
Andreessen Horowitz's biotech investment signals a strategic shift, highlighting evolving VC priorities and potential sectoral realignments.
The post Braveheart Bio seeks $319M in IPO backed by a16z, signaling VC firm’s expanding appetite beyond crypto appeared first on Crypto Briefing.
This content is automatically aggregated. Full credit goes to the original publisher (cryptobriefing.com).
